+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Evaluation of fluorescence polarization assays for measuring valproic acid, phenytoin, carbamazepine and phenobarbital in serum



Evaluation of fluorescence polarization assays for measuring valproic acid, phenytoin, carbamazepine and phenobarbital in serum



Therapeutic Drug Monitoring 24(3): 432-435



The authors evaluated the fluorescence polarization (FP) assay on the COBAS INTEGRA 700 using COBAS INTEGRA reagent system cassettes for estimating the antiepileptic drugs valproic acid, phenytoin, carbamazepine, and phenobarbital in serum. The study comprised the determination of precision, method comparison performed against a conventional HPLC assay and linearity studies, according to the National Committee for Clinical Laboratory Standards (NCCLS) protocols. Precision results were well acceptable for all FP assays. Intra-assay coefficients of variation (CVs) were from 1.3% to 2.4% for valproic acid, from 0.8% to 2.8% for phenytoin, from 1.7% to 3.3% for carbamazepine, and from 1.3% to 2.3% for phenobarbital. Interassay CVs for these drugs ranged from 1.5% to 2.6%, from 2.9% to 6.5%, from 1.8% to 3.7% and from 1.5% to 3.2%, respectively. Results of the FP assays showed excellent correlation with those from HPLC: r = 0.99 for valproic acid, r = 0.98 for phenytoin, r = 0.98 for carbamazepine and r = 0.99 for phenobarbital. Linearity was satisfactory, with all CVs below the acceptable level. With the COBAS INTEGRA 700 analyzer FP assays are fully automated, which is less laborious and saves time compared with HPLC. Moreover, the fast measuring procedure is convenient in short turnaround time (STAT) analysis. It is an analytically reliable and rapid system, which can be used successfully for the therapeutic monitoring of antiepileptic drugs in serum.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 010615825

Download citation: RISBibTeXText

PMID: 12021637

DOI: 10.1097/00007691-200206000-00017


Related references

Prediction of the free serum concentrations of phenytoin phenobarbital carbamazepine and carbamazepine 10 11 epoxide in patients on valproic acid co medication. Sunshine, I (Ed ) Recent Developments in Therapeutic Drug Monitoring And Clinical Toxicology; Second International Conference on Tdm (Therapeutic Drug Monitoring)-Toxicology, Barcelona, Spain Xii+791p Marcel Dekker, Inc : New York, New York, Usa; Basel, Switzerland Illus 401-407, 1992

Fluorescence polarization immunoassay for the monitoring of phenytoin pheno barbital carbamazepine and valproic acid. American Journal of Clinical Pathology 77(2): 238, 1982

Binding of fosphenytoin, phosphate ester pro drug of phenytoin, to human serum proteins and competitive binding with carbamazepine, diazepam, phenobarbital, phenylbutazone, phenytoin, valproic acid or warfarin. Research Communications in Molecular Pathology and Pharmacology 88(1): 51-62, 1995

Reduction of serum carnitine concentrations during anticonvulsant therapy with phenobarbital valproic acid phenytoin and carbamazepine in children. Journal of Pediatrics 119(5): 799-802, 1991

Serum aspirin-esterase activity in epileptic patients receiving treatment with phenobarbital, phenytoin, carbamazepine and valproic acid. International Journal of Clinical Pharmacology Research 9(1): 55-58, 1989

Three new assays for monitoring serum carbamazepine, phenytoin and valproic acid on the IMMULITE automated immunoassay analyzer. Clinical Chemistry 45(6 PART 2): A121, June, 1999

Drug interactions of phenobarbital phenytoin valproic acid and carbamazepine. Medical Journal of Kagoshima University 42(2): 159-175, 1990

Application of NCCLS protocols to establish performance characteristics of fluorescence polarization methods for phenobarbital, carbamazepine, and phenytoin. Clinical Chemistry 43(6 PART 2): S205, 1997

Cost-effective assays for use in monitoring carbamazepine, phenobarbital, and phenytoin in serum. Clinical Chemistry 35(8): 1782-1784, 1989

Effect of CYP3A5 genotypes on the pharmacokinetics of carbamazepine when used as monotherapy or co-administered with phenytoin, phenobarbital or valproic acid in Thai patients. Journal of Pharmacy & Pharmaceutical Sciences 16(4): 502-510, 2014

Effects of antiepileptic drugs on delivery and early childhood--comparison among mono-therapies of valproic acid, phenytoin, carbamazepine and phenobarbital. Rinsho Shinkeigaku 31(3): 266-269, 1991

Fluorescence polarization immunoassay for the measurement of phenytoin phenobarbital and primidone in serum. Clinical Chemistry: 932, 1985

Randomized 36-month comparative study of valproic acid , phenytoin , phenobarbital and carbamazepine efficacy in patients with newly diagnosed epilepsy with partial complex seizures. Journal of the Neurological Sciences 150(SUPPL ): S162-S163, 1997

Fluorescence polarization immunoassay IV. Determination of phenytoin and phenobarbital in human serum and plasma. Clinical Chemistry 28(11): 2278-2282, 1982

Computer evaluation of the EMIT assays carbamazepine, ethosuximide, phenobarbital, phenytoin, quinidine and theophylline on the Gemsaec centrifugal fast analyser. Journal of Automatic Chemistry 3(2): 92-96, 1981